Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for TNXP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 16.79M
March 31, 2026 14.21M
December 31, 2025 12.79M
September 30, 2025 10.17M
June 30, 2025 7.546M
March 31, 2025 6.878M
December 31, 2024 0.0439M
September 30, 2024 155.63M
June 30, 2024 9.833M
March 31, 2024 73.72M
December 31, 2023 58.61M
September 30, 2023 17.76M
June 30, 2023 10.76M
March 31, 2023 10.19M
December 31, 2022 12.24M
September 30, 2022 8.531M
June 30, 2022 5.071M
March 31, 2022 2.764M
December 31, 2021 2.481M
September 30, 2021 2.018M
June 30, 2021 1.732M
March 31, 2021 1.620M
December 31, 2020 1.03M
September 30, 2020 0.7008M
June 30, 2020 0.524M
Date Value
March 31, 2020 0.2468M
December 31, 2019 0.0427M
September 30, 2019 0.0079M
June 30, 2019 0.0032M
March 31, 2019 0.003M
December 31, 2018 0.0016M
September 30, 2018 0.0005M
June 30, 2018 0.0004M
March 31, 2018 0.0004M
December 31, 2017 0.0004M
September 30, 2017 0.0004M
June 30, 2017 0.00
March 31, 2017 0.0002M
December 31, 2016 0.0002M
September 30, 2016 0.0001M
June 30, 2016 0.0001M
March 31, 2016 0.0001M
December 31, 2015 0.0001M
September 30, 2015 0.0001M
June 30, 2015 0.0001M
March 31, 2015 0.0001M
December 31, 2014 0.0001M
September 30, 2014 0.0001M
June 30, 2014 0.00
March 31, 2014 0.00

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Exelixis, Inc. 248.88M
Inovio Pharmaceuticals, Inc. 82.34M
Heron Therapeutics, Inc. 189.46M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M